These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 30077711

  • 1. The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats.
    Zhang F, Xi L, Duan Y, Qin H, Wei M, Wu Y, Li B, Zhou Y, Wu X.
    Eur J Pharm Sci; 2018 Oct 15; 123():404-415. PubMed ID: 30077711
    [Abstract] [Full Text] [Related]

  • 2. Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats.
    Duan Y, Zhang F, Yuan W, Wei Y, Wei M, Zhou Y, Yang Y, Chang Y, Wu X.
    Life Sci; 2019 Sep 01; 232():116638. PubMed ID: 31288013
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
    Cao Y, Xiao Y, Zhou K, Yan J, Wang P, Yan W, Cai W.
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug 01; 317(2):G108-G115. PubMed ID: 30920307
    [Abstract] [Full Text] [Related]

  • 6. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis.
    Fiorucci S, Clerici C, Antonelli E, Orlandi S, Goodwin B, Sadeghpour BM, Sabatino G, Russo G, Castellani D, Willson TM, Pruzanski M, Pellicciari R, Morelli A.
    J Pharmacol Exp Ther; 2005 May 01; 313(2):604-12. PubMed ID: 15644430
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dehydrodiconiferyl alcohol, a lignan from Herpetospermum pedunculosum, alleviates cholestasis by activating pathways associated with the farnesoid X receptor.
    Wei X, Ma Y, Dong Z, Wang G, Lan X, Liao Z, Chen M.
    Phytomedicine; 2021 Jan 01; 80():153378. PubMed ID: 33113499
    [Abstract] [Full Text] [Related]

  • 9. The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice.
    Zhang F, Duan Y, Xi L, Wei M, Shi A, Zhou Y, Wei Y, Wu X.
    Chronobiol Int; 2018 May 01; 35(5):673-690. PubMed ID: 29381405
    [Abstract] [Full Text] [Related]

  • 10. Xenobiotic Nuclear Receptor Signaling Determines Molecular Pathogenesis of Progressive Familial Intrahepatic Cholestasis.
    Kim KH, Choi JM, Li F, Arizpe A, Wooton-Kee CR, Anakk S, Jung SY, Finegold MJ, Moore DD.
    Endocrinology; 2018 Jun 01; 159(6):2435-2446. PubMed ID: 29718219
    [Abstract] [Full Text] [Related]

  • 11. [Expression of FXR mRNA, PPAR alpha mRNA and bile acid metabolism related genes in intrahepatic cholestasis of pregnant rats].
    Shi QY, Lin YG, Zhou X, Lin YQ, Yan S.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Dec 01; 18(12):927-30. PubMed ID: 21205480
    [Abstract] [Full Text] [Related]

  • 12. Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice.
    Fu ZD, Cui JY, Klaassen CD.
    J Lipid Res; 2014 Dec 01; 55(12):2576-86. PubMed ID: 25278499
    [Abstract] [Full Text] [Related]

  • 13. Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064.
    Moscovitz JE, Kong B, Buckley K, Buckley B, Guo GL, Aleksunes LM.
    Toxicol Appl Pharmacol; 2016 Nov 01; 310():60-67. PubMed ID: 27609522
    [Abstract] [Full Text] [Related]

  • 14. Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo.
    Yang F, Wang Y, Li G, Xue J, Chen ZL, Jin F, Luo L, Zhou X, Ma Q, Cai X, Li HR, Zhao L.
    Br J Pharmacol; 2018 Mar 01; 175(5):810-829. PubMed ID: 29235094
    [Abstract] [Full Text] [Related]

  • 15. Protective effects of cilostazol via the HNF1α/FXR signalling pathway and anti-apoptotic mechanisms in a rat model of estrogen-induced intrahepatic cholestasis.
    Hassan M, Salem MB, Hammam OA, ElZallat M.
    Sci Rep; 2024 Oct 01; 14(1):22751. PubMed ID: 39349582
    [Abstract] [Full Text] [Related]

  • 16. Beneficial effects of colchicine on 17alpha-ethynylestradiol-induced cholestasis in rats.
    Zhou ZX, Wang T, Jiang ZZ, Shang J, Liu L, Zhang Y, Zhu D, Huang X, Zhang S, Hu Y, Wang JY, Zhang LY.
    Arzneimittelforschung; 2011 Oct 01; 61(3):173-9. PubMed ID: 21528642
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice.
    El Kasmi KC, Ghosh S, Anderson AL, Devereaux MW, Balasubramaniyan N, D'Alessandro A, Orlicky DJ, Suchy FJ, Shearn CT, Sokol RJ.
    Hepatology; 2022 Feb 01; 75(2):252-265. PubMed ID: 34387888
    [Abstract] [Full Text] [Related]

  • 18. Hepatoprotection of auraptene from the peels of citrus fruits against 17α-ethinylestradiol-induced cholestasis in mice by activating farnesoid X receptor.
    Wang J, Fu T, Dong R, Wang C, Liu K, Sun H, Huo X, Ma X, Yang X, Meng Q.
    Food Funct; 2019 Jul 17; 10(7):3839-3850. PubMed ID: 31210195
    [Abstract] [Full Text] [Related]

  • 19. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
    Li T, Xu L, Zheng R, Wang X, Li L, Ji H, Hu Q.
    Phytomedicine; 2020 Mar 17; 68():153153. PubMed ID: 32018210
    [Abstract] [Full Text] [Related]

  • 20. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X, Fu T, Wang C, Ning C, Liu K, Liu Z, Sun H, Ma X, Huo X, Yang X, Zou M, Meng Q.
    Toxicol Appl Pharmacol; 2018 Jun 01; 348():105-116. PubMed ID: 29660435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.